Latigo Biotherapeutics, Inc.'s Quiet Period Will End on September 16th (NASDAQ:LTGO)
MarketBeat
Latigo Biotherapeutics' (NASDAQ:LTGO - Get Free Report) quiet period is set to end on Wednesday, September 16th. Latigo Biotherapeutics had issued 19,200,000 shares in its public offering on August 7th. The total size of the offering was $345,600,000 based on an initial share price of $18.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
NASDAQ:LTGO
